Chuvashia Inappropriate Prescribing Study

NCT06845397 | Completed

• 1 other identifier: 06-07/23
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

This is a cross-sectional study based on an outpatient registry. All medical therapy will be registered in order to assess inappropriate prescribing's, in accordance with the criteria PROMPT and BEERS, also in accordance with the officially approved instructions for the use of this medicinal product.

Conditions

Multimorbidity, Cardiovascular Diseases

Keywords

multimorbidity; self-medication; drugs; over-the-counter (OTC) drugs; prescription drugs; adherence; inappropriate prescribing

Outcome Measures

Primary Outcomes (1)

• frequency of inappropriate drug prescriptions

  Рrescribing medications in an inadequate dose, with the wrong frequency, and the wrong duration of treatment, failure to prescribe a potentially effective drug in the presence of clinical indications, self-medication was considered irrational treatment and was assessed as the end point. It also includes prescribing medications that are likely to have a negative effect on the course of concomitant pathology, as well as drug interactions, in accordance with the criteria PROMPT and BEERS.

  Assessed at baseline

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

This is a cross-sectional study based on an outpatient registry. All medical therapy will be registered in order to assess inappropriate prescribing's, in accordance with the criteria PROMPT and BEERS, also in accordance with the officially approved instructions for the use of this medicinal product.

You may qualify if:

• Age \> 50 years old, multimorbidity, signed Patients' Informed Consent

Sponsors & Collaborators

• National Medical Research Center for Therapy and Preventive Medicine: lead
• BU "Respublikanski Kardiologicheski Dispanser" Minzdrava Chuvashii, Cheboksary: collaborator

Study Sites (1)

Respublikanski Kardiologicheski Dispanser Minzdrava Chuvashii

Cheboksary, Russia

Location

MeSH Terms

Conditions

Cardiovascular Diseases; Ornithine Carbamoyltransferase Deficiency Disease

Condition Hierarchy (Ancestors)

Urea Cycle Disorders, Inborn; Brain Diseases, Metabolic, Inborn; Brain Diseases, Metabolic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Genetic Diseases, X-Linked; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Amino Acid Metabolism, Inborn Errors; Metabolism, Inborn Errors; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Officials

• Sergey Martsevich, M.D., Professor

  National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Month
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 20, 2025
• First Posted: February 25, 2025
• Study Start: December 12, 2023
• Primary Completion: August 7, 2024
• Study Completion: August 7, 2024
• Last Updated: June 10, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

RU (1)